Skip to content

Immunity and Nasal Fungal Colonization

Host Immunity and Nasal Fungal Colonization

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05231499
Enrollment
58
Registered
2022-02-09
Start date
2018-08-20
Completion date
2020-07-27
Last updated
2022-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonization, Asymptomatic

Keywords

colonization, microbiota, fungi, immunocompromised

Brief summary

Fungal colonization causes opportunistic infection that may manifest when the host's immune status deteriorates. The purpose of this study was to determine the prevalence of fungal colonization in immunocompromised subjects compared to healthy controls.

Interventions

regular saline nasal rinse

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Immunocompromised subjects included those who had known risk factors for fungal infection, including malignant diseases, diabetes, autoimmune disorders, renal or hepatic insufficiency, organ transplantation, or use of immunosuppressants * Healthy volunteers had neither sinonasal symptoms nor nasal endoscopic inflammation.

Exclusion criteria

* Patients were excluded if they were under 20 years old, were receiving antifungal medication, or were pregnant.

Design outcomes

Primary

MeasureTime frame
nasal lavage pooled fungal microbiota1 month

Secondary

MeasureTime frame
nasal lavage aspergillus qPCR1 month

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026